Multiple Ascending Doses of BMS-986326 in Participants with Discoid Lupus Erythematosus, Subacute Cutaneous Lupus Erythematosus, or Systemic Lupus Erythematosus

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2022-503009-39-00

Acronym

IM034-1000

Enrollment

Registered

2023-11-20

Start date

2024-06-04

Completion date

Unknown

Last updated

2025-06-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Discoid Lupus Erythematosus, Subacute Cutaneous Lupus Erythematosus, Systemic Lupus Erythematosus

None listed

Sex/Gender

All

Age

18 Years to No maximum

Bulgaria, Germany, Netherlands, Poland, Romania, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026